Diffusion Pharmaceuticals DFFN Balance Sheet

Income Statement

Quarter End	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	37.84M	33.57M	29.18M	26.32M	22.64M	18.41M	15.7M	12.04M
Total Current Assets	37.82M	33.57M	29.18M	26.32M	22.64M	18.41M	15.7M	11.84M
Cash and Equivalents	37.31M	9.87M	5.97M	6.59M	10.11M	14.65M	15M	10.43M
Total Non-Current Assets	15k	0	0	0	0	0	0	194k
Total Liabilities	2.93M	2.96M	2.52M	2.27M	2.42M	2.13M	1.47M	2.46M
Total Current Liabilities	2.93M	2.96M	2.52M	2.27M	2.42M	2.13M	1.47M	2.46M
Total Non-Current Liabilities	0	0	0	0	0	0	0	0
Common Equity	102k	7k	2k	2k	2k	2k	2k	6k
Retained Earnings	-130.01M	-134.53M	-138.72M	-141.52M	-145.6M	-149.69M	-151.8M	-52.08M

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	17.48M	26.15M	18.2M	24.11M	27.73M	37.84M	22.64M	9.97M
Total Current Assets	1.6M	9.67M	8.91M	14.65M	18.78M	37.82M	22.64M	9.96M
Cash and Equivalents	1.55M	8.9M	7.99M	14.18M	18.52M	37.31M	10.11M	7.79M
Total Non-Current Assets	9.19M	21.23M	15.61M	20.13M	24.81M	34.91M	20.22M	7.38M
Total Liabilities	8.3M	4.92M	2.59M	3.98M	2.92M	2.93M	2.42M	2.6M
Total Current Liabilities	4.44M	2.69M	804k	1.72M	2.44M	2.93M	2.42M	2.6M
Total Non-Current Liabilities	4.41M	2.23M	1.79M	2.26M	480k	0	0	0
Total Equity	9.19M	21.23M	15.61M	20.13M	24.81M	34.91M	20.22M	7.38M
Common Equity	10k	15k	3k	33k	64k	102k	2k	6k
Retained Earnings	-60.19M	-61.56M	-79.92M	-91.72M	-105.91M	-130.01M	-145.6M	-54.44M